Literature DB >> 3420563

Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.

P J Guest1, M G Britton, H C Grundy, M D Yates.   

Abstract

We report a case in which erythromycin was used in place of rifampicin after a severe reaction to the latter in the treatment of pulmonary Mycobacterium kansasii infection.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3420563      PMCID： PMC461320          DOI： 10.1136/thx.43.6.488

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  7 in total

1.  In-vitro activity of erythromycin against atypical mycobacteria.

Authors:  A Molavi; L Weinstein
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

Review 2.  Infections caused by opportunist mycobacteria: a review.

Authors:  J M Grange; M D Yates
Journal:  J R Soc Med       Date:  1986-04       Impact factor: 5.344

3.  Erythromycin for BCG cold abscess.

Authors:  G Singh; M Singh
Journal:  Lancet       Date:  1984-10-27       Impact factor: 79.321

4.  Short-course chemotherapy for mycobacteriosis kansasii?

Authors:  D E Schraufnagel; J A Leech; M N Schraufnagel; B Pollak
Journal:  Can Med Assoc J       Date:  1984-01-01       Impact factor: 8.262

5.  Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination.

Authors:  S P Hanley; J Gumb; J T Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

6.  The nature of mycobacterial disease in south east England, 1977-84.

Authors:  M D Yates; J M Grange; C H Collins
Journal:  J Epidemiol Community Health       Date:  1986-12       Impact factor: 3.710

7.  Erythromycin in the management of troublesome BCG lesions.

Authors:  J T Power; I C Stewart; J D Ross
Journal:  Br J Dis Chest       Date:  1984-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.